Table on assessment times for parallel import 2020
Updated 17 March 2021
Table 1. Average assessment times for parallel import
Parallel import | Average assessment time | Target days | Difference between assessment time and target days | No. of cases measured No. of drug IDs |
No. of cases within target | Share of cases within targer in per cent |
1st quarter 2019 | 82 | 60 | 22 | 64 | 22 | 34 |
2nd quarter 2019 |
63 | 60 | 3 | 82 | 60 | 73 |
3rd quarter 2019 |
76 | 60 | 16 | 207 | 103 | 50 |
4th quarter 2019 |
108 | 60 | 48 | 90 | 30 | 33 |
1st quarter 2020 |
104 | 60 | 44 | 210 | 62 | 30 |
2nd quarter 2020 |
114 | 60 | 54 | 142 | 70 | 49 |
3rd quarter 2020 |
92 | 60 | 32 | 181 | 113 | 62 |
4th quarter 2020 |
69 | 60 | 9 | 94 | 68 | 72 |
Table 2. Average assessment times for parallel import - Human medicines
Parallel import | Average assessment time | Target days | Difference between assessment time and target days | No. of cases measured No. of drug IDs |
No. of cases within target | Share of cases within targer in per cent |
4th quarter 2018 |
65 | 60 | 5 | 59 | 28 47 | |
1st quarter 2019 |
82 | 60 | 22 | 64 | 22 | 34 |
2nd quarter 2019 |
63 | 60 | 3 | 82 | 60 | 73 |
3rd quarter 2019 |
76 | 60 | 16 | 205 | 102 | 50 |
4th quarter 2019 |
108 | 60 | 48 | 90 | 30 | 33 |
1st quarter 2020 |
103 | 60 | 43 | 202 | 61 | 30 |
2nd quarter 2020 |
112 | 60 | 52 | 137 | 69 | 50 |
3rd quarter 2020 |
90 | 60 | 30 | 177 | 112 | 63 |
4th quarter 2020 |
69 | 60 | 9 | 94 | 68 | 72 |
Table 3. Average assessment times for parallel import - Veterinary medicines
Parallel import | Average assessment time | Target days | Difference between assessment time and target days | No. of cases measured No. of drug IDs |
No. of cases within target | Share of cases within targer in per cent |
1st quarter 2019 |
60 | 0 | ||||
2nd quarter 2019 |
60 | 0 | ||||
3rd quarter 2019 |
58 | 60 | -2 | 2 | 1 | 50 |
4th quarter 2019 |
60 | 0 | ||||
1st quarter 2020 |
114 | 60 | 54 | 8 | 1 | 13 |
2nd quarter 2020 |
177 | 60 | 117 | 5 | 1 | 20 |
3rd quarter 2020 |
172 | 60 | 112 | 4 | 1 | 25 |
4th quarter 2020 |
60 | 0 |